Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026)

Bio-Techne (TECH) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,283.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 506.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -569.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 6,537.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bio-Techne 11.23 Bn 11.02 Bn 208.29 Mn -748.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -748.00
Dec 31, 2025 -557.00
Sep 30, 2025 -447,337.00
Jun 30, 2025 -5,690.00
Mar 31, 2025 -1,357.00
Dec 31, 2024 -1,501.00
Sep 30, 2024 -1,516.00
Jun 30, 2024 175.00
Mar 31, 2024 -247.00
Dec 31, 2023 -1,050.00
Sep 30, 2023 206.00
Jun 30, 2023 154.00
Mar 31, 2023 516.00
Dec 31, 2022 -4,627.00
Sep 30, 2022 447,884.00
Jun 30, 2022 5,609.00
Mar 31, 2022 -344.00
Dec 31, 2021 1,670.00
Sep 30, 2021 1,609.00
Jun 30, 2021 -283.00